117 related articles for article (PubMed ID: 31747325)
1. Association of Carcinoembryonic Antigen with Mortality in an Insurance Applicant Population.
Rigatti SJ; Stout R
J Insur Med; 2019; 48(1):24-35. PubMed ID: 31747325
[No Abstract] [Full Text] [Related]
2. Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants.
Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
J Insur Med; 2007; 39(4):251-8. PubMed ID: 18522142
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of serum CA 195 and carcinoembryonic antigen in metastatic carcinoma.
Verdi CJ; Ahmann FR; Schifman RB; Elvick AL; Ahmann ME; Marx PC
Cancer; 1993 Jun; 71(11):3625-32. PubMed ID: 8490911
[TBL] [Abstract][Full Text] [Related]
4. Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer.
Margalit O; Mamtani R; Yang YX; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
Eur J Cancer; 2018 May; 94():1-5. PubMed ID: 29502035
[TBL] [Abstract][Full Text] [Related]
5. All-Cause Mortality for Life Insurance Applicants with the Presence of Bundle Branch Block.
Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Zamarripa D; Gill S
J Insur Med; 2019; 48(1):36-47. PubMed ID: 31219368
[No Abstract] [Full Text] [Related]
6. All-Cause Mortality for Life Insurance Applicants with a History of Prostate Cancer.
Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Beckman M; Rigatti SJ; Gill S
J Insur Med; 2017; 47(2):95-106. PubMed ID: 29490159
[TBL] [Abstract][Full Text] [Related]
7. All-Cause Mortality for Life Insurance Applicants with a Family History of Coronary Artery Disease Before 60.
Freitas SA; MacKenzie R; Wylde DN; Von Bergen J; Holowaty JC; Beckman M; Rigatti SJ; Gill S
J Insur Med; 2018 Jan; 47(3):159-171. PubMed ID: 30192720
[TBL] [Abstract][Full Text] [Related]
8. 2014 CRL Build Study of Life Insurance Applicants.
Fulks M; Dolan VF; Stout RL
J Insur Med; 2016; 46(1):13-9. PubMed ID: 27562108
[TBL] [Abstract][Full Text] [Related]
9. Time-dependency of the prognostic effect of carcinoembryonic antigen and p53 protein in colorectal adenocarcinoma.
Diez M; Pollan M; Müguerza JM; Gaspar MJ; Duce AM; Alvarez MJ; Ratia T; Herñandez P; Ruiz A; Granell J
Cancer; 2000 Jan; 88(1):35-41. PubMed ID: 10618603
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.
Turkdogan S; Forest VI; Hier MP; Tamilia M; Florea A; Payne RJ
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):55. PubMed ID: 30223887
[TBL] [Abstract][Full Text] [Related]
11. All-Cause Mortality for Life Insurance Applicants with a History of Breast Cancer.
Freitas SA; MacKenzie R; Wylde DN; Roudebush BT; Bergstrom RL; Holowaty JC; Hart A; Rigatti SJ; Gill S
J Insur Med; 2017; 47(1):6-22. PubMed ID: 28836905
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages.
Huang EY; Chang JC; Chen HH; Hsu CY; Hsu HC; Wu KL
BMC Cancer; 2018 Mar; 18(1):321. PubMed ID: 29580202
[TBL] [Abstract][Full Text] [Related]
13. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen.
Safi F; Kohler I; Röttinger E; Beger H
Cancer; 1991 Aug; 68(3):574-82. PubMed ID: 2065278
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
15. Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator.
Patel DD; Bhatavdekar JM; Ghosh N; Vora HH; Karelia NH; Shah NG; Suthar TP; Balar DB; Trivedi CR
Cancer; 1994 Feb; 73(3):570-4. PubMed ID: 8299078
[TBL] [Abstract][Full Text] [Related]
16. A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer.
Huang YY; Lee PI; Liu MC; Chen CC; Huang KC; Huang AT
Clin Nucl Med; 2015 Oct; 40(10):e465-9. PubMed ID: 26204213
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
18. CD66b, CD66c and carcinoembryonic antigen (CEA) are independently regulated markers in sera of tumor patients.
Grunert F; Daniel S; Nagel G; von Kleist S; Jantscheff P
Int J Cancer; 1995 Nov; 63(3):349-55. PubMed ID: 7591230
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
[TBL] [Abstract][Full Text] [Related]
20. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
